Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 36

Sort by

Sort Order Select

Journal Articles

Lymphoma Cell Sorting to Enrich Low Degree Infiltration Clonal B-Cells for Diagnostic Delineation of Molecular Genetic Background By NGS

Veronika Ecker, Martha-Lena Mueller, Manja Meggendorfer, Christiane Eder, Constance Regina Baer, Claudia Haferlach, Torsten Haferlach, Wolfgang Kern

Blood (2023) 142 (Supplement 1): 6101.

https://doi.org/10.1182/blood-2023-188953

Published: 2023

Journal Articles

WT1 Mutations Are Secondary Events In AML and Show Varying Frequencies Within Genetic Subgroups and Different Impact On Prognosis

Susanne Schnittger, PhD, Christiane Eder, PhD, Tamara Alpermann, Frank Dicker, PhD, Madlen Ulke, Alexander Kohlmann, PhD, Sabrina Kuznia, MSc, Wolfgang Kern, MD, Torsten Haferlach, MD, Claudia Haferlach, MD

Blood (2013) 122 (21): 2542.

https://doi.org/10.1182/blood.V122.21.2542.2542

Published: 2013

Journal Articles

Acute Myeloid Leukemia With t(8;21)/ RUNX1-RUNX1T1 demonstrate a High Number Of Secondary Genetic Lesions: Frequency and Impact On Clinical Outcome

Maria Theresa Krauth, MD, Christiane Eder, PhD, Tamara Alpermann, Wolfgang Kern, MD, Claudia Haferlach, MD, Torsten Haferlach, MD, Susanne Schnittger, PhD

Blood (2013) 122 (21): 2565.

https://doi.org/10.1182/blood.V122.21.2565.2565

Published: 2013

Journal Articles

Characterization and Quantification Of Rare BCR-ABL1 Fusion Transcripts

Susanne Schnittger, PhD, Frank Dicker, PhD, Tamara Alpermann, Christiane Eder, PhD, Annette Fasan, PhD, Simone Weber, Sabine Jeromin, PhD, Manja Meggendorfer, PhD, Wolfgang Kern, MD, Torsten Haferlach, MD, Claudia Haferlach, MD

Blood (2013) 122 (21): 4013.

https://doi.org/10.1182/blood.V122.21.4013.4013

Published: 2013

Journal Articles

Risk Stratification In Chronic Lymphocytic Leukemia Patients With IGHV3-21 Gene Usage According To Presence Of Stereotypy and Mutations In SF3B1

Sabine Jeromin, PhD, Frank Dicker, PhD, Katharina Bayer, Sandra Weissmann, PhD, Christiane Eder, PhD, Manja Meggendorfer, PhD, Tamara Alpermann, Alexander Kohlmann, PhD, Torsten Haferlach, MD, Wolfgang Kern, MD, Claudia Haferlach, MD, Susanne Schnittger, PhD

Blood (2013) 122 (21): 4114.

https://doi.org/10.1182/blood.V122.21.4114.4114

Published: 2013

Journal Articles

Comprehensive Analysis Of U2AF1 Mutations In 843 Patients With Myeloid Neoplasms With Respect To Other Genetic Alterations

Manja Meggendorfer, PhD, Christiane Eder, PhD, Sabine Jeromin, PhD, Claudia Haferlach, MD, Wolfgang Kern, MD, Torsten Haferlach, MD, Susanne Schnittger, PhD

Blood (2013) 122 (21): 4973.

https://doi.org/10.1182/blood.V122.21.4973.4973

Published: 2013

Journal Articles

Comparison Of Mutation Patterns Between Diagnosis and Relapse In 556 Adult Patients With AML Shows High Variability Of Stability

Susanne Schnittger, PhD, Niroshan Nadarajah, MSc, Tamara Alpermann, Christiane Eder, PhD, Alexander Kohlmann, PhD, Sabrina Kuznia, MSc, Sandra Weissmann, PhD, Annette Fasan, PhD, Simone Weber, Andreia Albuquerque, PhD, Sabine Jeromin, PhD, Manja Meggendorfer, PhD, Frank Dicker, PhD, Wolfgang Kern, MD, Claudia Haferlach, MD, Torsten Haferlach, MD

Blood (2013) 122 (21): 4978.

https://doi.org/10.1182/blood.V122.21.4978.4978

Published: 2013

Journal Articles

RARS-T Patients Harbor SF3B1 Mutations In 90.2% and Can Be Characterized By Mutations In ASXL1 and Other Spliceosome Genes In Most Of The Remaining Cases

Sabine Jeromin, PhD, Christiane Eder, PhD, Sandra Weissmann, PhD, Manja Meggendorfer, PhD, Tamara Alpermann, Alexander Kohlmann, PhD, Wolfgang Kern, MD, Claudia Haferlach, MD, Torsten Haferlach, MD, Susanne Schnittger, PhD

Blood (2013) 122 (21): 2764.

https://doi.org/10.1182/blood.V122.21.2764.2764

Published: 2013

Journal Articles

Comprehensive Genetic Analyses Of 213 PMF Patients Revealed 13% Of SRSF2 Mutations Being Strongly Correlated To ASXL1 Mutations

Manja Meggendorfer, PhD, Tamara Alpermann, Christiane Eder, PhD, Claudia Haferlach, MD, Wolfgang Kern, MD, Torsten Haferlach, MD, Susanne Schnittger, PhD

Blood (2013) 122 (21): 2828.

https://doi.org/10.1182/blood.V122.21.2828.2828

Published: 2013

Journal Articles

Tyrosine Kinase Inhibitor Treated CML Patients Harboring Philadelphia-Negative Cytogenetically Aberrant Clones Show Molecular Mutations In 31% Of Cases Not Present At Diagnosis: A High-Throughput Amplicon Sequencing Study Of 29 Genes

Susanne Schnittger, PhD, Sabrina Kuznia, MSc, Manja Meggendorfer, PhD, Niroshan Nadarajah, MSc, Sabine Jeromin, PhD, Tamara Alpermann, Andreas Roller, PhD, Andreia Albuquerque, PhD, Sandra Weissmann, PhD, Thomas Ernst, Christiane Eder, PhD, Frank Dicker, PhD, Wolfgang Kern, MD, Alexander Kohlmann, PhD, Torsten Haferlach, MD, Andreas Hochhaus, MD, Claudia Haferlach, MD

Blood (2013) 122 (21): 611.

https://doi.org/10.1182/blood.V122.21.611.611

Published: 2013

Journal Articles

Evaluation Of Different NPM1 Mutations In AML Patients According To Clinical, Cytogenetic and Molecular Features and Impact On Outcome

Tamara Alpermann, Claudia Haferlach, MD, Frank Dicker, PhD, Christiane Eder, PhD, Alexander Kohlmann, PhD, Wolfgang Kern, MD, Torsten Haferlach, MD, Susanne Schnittger, PhD

Blood (2013) 122 (21): 51.

https://doi.org/10.1182/blood.V122.21.51.51

Published: 2013

Journal Articles

Analysis of 12 Genes in 268 Cases with CMML Identifies ASXL1 Mutations As the Most Important Genetic Alteration Associated with Adverse Outcome

Susanne Schnittger, PhD, Manja Meggendorfer, PhD, Vera Grossmann, MSc, Tamara Alpermann, Christiane Eder, PhD, Alexander Kohlmann, PhD, Wolfgang Kern, MD, Claudia Haferlach, MD, Torsten Haferlach, MD

Blood (2012) 120 (21): 3491.

https://doi.org/10.1182/blood.V120.21.3491.3491

Published: 2012

Journal Articles

High BAALC Expression in Cytogenetically Normal Acute Myeloid Leukemia Strongly Correlates with Adverse Markers Such As RUNX1 mut, MLL -PTD and FLT3 -ITD and Is Useful for Disease Monitoring

Simone Weber, Tamara Alpermann, Christiane Eder, PhD, Frank Dicker, PhD, Sabine Jeromin, PhD, Alexander Kohlmann, PhD, Annette Fasan, PhD, Claudia Haferlach, MD, Wolfgang Kern, MD, Torsten Haferlach, MD, Susanne Schnittger, PhD

Blood (2012) 120 (21): 1376.

https://doi.org/10.1182/blood.V120.21.1376.1376

Published: 2012

Journal Articles

Acute Erythroid Leukemia (AEL) Can Be Separated Into Distinct Prognostic Subsets Based On Cytogenetic and Molecular Genetic Characteristics

Vera Grossmann, MSc, Claudia Haferlach, MD, Susanne Schnittger, PhD, Ulrike Bacher, MD, Franziska Poetzinger, Sandra Weissmann, PhD, Andreas Roller, PhD, Christiane Eder, PhD, Annette Fasan, PhD, Melanie Zenger, Marita Staller, Wolfgang Kern, MD, Alexander Kohlmann, PhD, Torsten Haferlach, MD

Blood (2012) 120 (21): 1394.

https://doi.org/10.1182/blood.V120.21.1394.1394

Published: 2012

Journal Articles

SF3B1 Mutations Are Detectable in 48.9% of Acute Myeloid Leukemia with Normal Karyotype (AML-NK) and ≥15% Ring Sideroblasts and Are Closely Related to FLT3 -ITD and RUNX1 Mutations

Sabine Jeromin, PhD, Ulrike Bacher, MD, Katharina Bayer, Frank Dicker, PhD, Christiane Eder, PhD, Annette Fasan, PhD, Vera Grossmann, MSc, Alexander Kohlmann, PhD, Wolfgang Kern, MD, Claudia Haferlach, MD, Susanne Schnittger, PhD, Torsten Haferlach, MD

Blood (2012) 120 (21): 406.

https://doi.org/10.1182/blood.V120.21.406.406

Published: 2012

Journal Articles

Comparison of Mutation Patterns Between Diagnosis and Relapse in 444 Patients with Acute Myeloid Leukemia Shows High Variability of Stability and Influence On Time to Relapse

Susanne Schnittger, PhD, Tamara Alpermann, Niroshan Nadarajah, MSc, Vera Grossmann, MSc, Christiane Eder, PhD, Alexander Kohlmann, PhD, Annette Fasan, PhD, Frank Dicker, PhD, Wolfgang Kern, MD, Claudia Haferlach, MD, Torsten Haferlach, MD

Blood (2012) 120 (21): 408.

https://doi.org/10.1182/blood.V120.21.408.408

Published: 2012

Journal Articles

Sole Trisomy 8 in AML: Concomitant Molecular Markers, Stability of Genetic Patterns and Impact On Outcome.

Tamara Alpermann, Claudia Haferlach, MD, Christiane Eder, PhD, Alexander Kohlmann, PhD, Wolfgang Kern, MD, Torsten Haferlach, MD, Susanne Schnittger, PhD

Blood (2012) 120 (21): 2503.

https://doi.org/10.1182/blood.V120.21.2503.2503

Published: 2012

Journal Articles

Evaluation of BRAF V600E, NRAS and KRAS Mutations As Well As IGHV Usage for Diagnostic Use in Hairy Cell Leukemia, Hairy Cell Leukemia-Variant and Splenic Marginal Zone Lymphoma.

Susanne Schnittger, PhD, Frank Dicker, PhD, Christiane Eder, PhD, Sabine Jeromin, PhD, Tamara Alpermann, Claudia Haferlach, MD, Torsten Haferlach, MD, Wolfgang Kern, MD

Blood (2012) 120 (21): 2679.

https://doi.org/10.1182/blood.V120.21.2679.2679

Published: 2012

Journal Articles

CML Patients with Philadelphia-Negative Clones Occurring During Treatment with Tyrosine Kinase Inhibitors Harbor Molecular Mutations Typical for MDS.

Susanne Schnittger, PhD, Christiane Eder, PhD, Alexander Kohlmann, PhD, Frank Dicker, PhD, Wolfgang Kern, MD, Torsten Haferlach, MD, Claudia Haferlach, MD

Blood (2012) 120 (21): 2775.

https://doi.org/10.1182/blood.V120.21.2775.2775

Published: 2012

Journal Articles

High Incidence of RAS Signalling Pathway Mutations in MLL –rearranged Acute Myeloid Leukemia

Vera Grossmann, MSc, Susanne Schnittger, PhD, Alexander Kohlmann, PhD, Christiane Eder, PhD, Annette Fasan, PhD, Wolfgang Kern, MD, Torsten Haferlach, MD, Claudia Haferlach, MD

Blood (2012) 120 (21): 539.

https://doi.org/10.1182/blood.V120.21.539.539

Published: 2012

NARROW

Lymphoma Cell Sorting to Enrich Low Degree Infiltration Clonal B-Cells for Diagnostic Delineation of Molecular Genetic Background By NGS

WT1 Mutations Are Secondary Events In AML and Show Varying Frequencies Within Genetic Subgroups and Different Impact On Prognosis

Acute Myeloid Leukemia With t(8;21)/ RUNX1-RUNX1T1 demonstrate a High Number Of Secondary Genetic Lesions: Frequency and Impact On Clinical Outcome

Characterization and Quantification Of Rare BCR-ABL1 Fusion Transcripts

Risk Stratification In Chronic Lymphocytic Leukemia Patients With IGHV3-21 Gene Usage According To Presence Of Stereotypy and Mutations In SF3B1

Comprehensive Analysis Of U2AF1 Mutations In 843 Patients With Myeloid Neoplasms With Respect To Other Genetic Alterations

Comparison Of Mutation Patterns Between Diagnosis and Relapse In 556 Adult Patients With AML Shows High Variability Of Stability

RARS-T Patients Harbor SF3B1 Mutations In 90.2% and Can Be Characterized By Mutations In ASXL1 and Other Spliceosome Genes In Most Of The Remaining Cases

Comprehensive Genetic Analyses Of 213 PMF Patients Revealed 13% Of SRSF2 Mutations Being Strongly Correlated To ASXL1 Mutations

Tyrosine Kinase Inhibitor Treated CML Patients Harboring Philadelphia-Negative Cytogenetically Aberrant Clones Show Molecular Mutations In 31% Of Cases Not Present At Diagnosis: A High-Throughput Amplicon Sequencing Study Of 29 Genes

Evaluation Of Different NPM1 Mutations In AML Patients According To Clinical, Cytogenetic and Molecular Features and Impact On Outcome

Analysis of 12 Genes in 268 Cases with CMML Identifies ASXL1 Mutations As the Most Important Genetic Alteration Associated with Adverse Outcome

High BAALC Expression in Cytogenetically Normal Acute Myeloid Leukemia Strongly Correlates with Adverse Markers Such As RUNX1 mut, MLL -PTD and FLT3 -ITD and Is Useful for Disease Monitoring

Acute Erythroid Leukemia (AEL) Can Be Separated Into Distinct Prognostic Subsets Based On Cytogenetic and Molecular Genetic Characteristics

SF3B1 Mutations Are Detectable in 48.9% of Acute Myeloid Leukemia with Normal Karyotype (AML-NK) and ≥15% Ring Sideroblasts and Are Closely Related to FLT3 -ITD and RUNX1 Mutations

Comparison of Mutation Patterns Between Diagnosis and Relapse in 444 Patients with Acute Myeloid Leukemia Shows High Variability of Stability and Influence On Time to Relapse

Sole Trisomy 8 in AML: Concomitant Molecular Markers, Stability of Genetic Patterns and Impact On Outcome.

Evaluation of BRAF V600E, NRAS and KRAS Mutations As Well As IGHV Usage for Diagnostic Use in Hairy Cell Leukemia, Hairy Cell Leukemia-Variant and Splenic Marginal Zone Lymphoma.

CML Patients with Philadelphia-Negative Clones Occurring During Treatment with Tyrosine Kinase Inhibitors Harbor Molecular Mutations Typical for MDS.

High Incidence of RAS Signalling Pathway Mutations in MLL –rearranged Acute Myeloid Leukemia

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only